Adam Sues submits:
Acme United Corp (ACU), a supplier of cutting, measuring and safety products, reported 2nd quarter results this week. ACU is another small undervalued stock in a boring business line that has been overlooked by the market.
The stock was hit hard during the recession, and is slowly starting to regain its 2006-2008 levels.
Jason Nevader submits:
Gulf Resources (GFRE) will be reporting second quarter results in a little less than two weeks and the consensus analyst estimate of $36.97 million in revenues does not take into consideration Gulf’s seasonal sales trends and bromine price increases. By my estimate, revenues could be $46.0 million in the quarter. Gulf’s revenues are broken down into bromine, crude salt, and specialty chemical sales. Bromine reserves are found mainly in the U.S., in the Dead Sea and in China, which account for 96% of the world’s total bromine production. Gulf Resources is the largest bromine producer in China and one of a few companies with a bromine exploration license in China. The bromine demand in China is larger than the domestic supply, which has led to significant price increases. The Company has $56 million in cash ($1.60 per share in cash) and no debt.
Bromine Sales
VFC submits:
It’s been a while since I last posted about Capstone Turbine, a leading producer of low-emission, clean technology microturbine systems, but with the stock back to trading for at or below a buck and with products under development that could significantly impact the alternative energy market, it’s definitely worth taking a look at this one as a ‘green pick.’
Although still climbing towards profitability, Capstone already has a growing world wide distribution network in place and is constantly improving its products and developing new ones with an eye towards the future of green technology.
Jeff Moore submits:
Reading Charles & Colvard’s (CTHR) 8K with earnings and revenue info, all I have to say is "Wow. This has the potential to be really impressive. They sold a ton of stuff, but didn’t get paid for it."
This quarter, over the same one from a year ago, revenue is up 152%. Accounts receivable are up by over 700%; from $.363 million, to $2.59 million. The bottom line improved by $1.5 million, meaning that the company earned 2 cents a share. For a different perspective on revenues, accounts receivable are up over the last 6 months from $1.04 million, when they had $2.36 million in revenue, to $2.58 million at the end of the present filing period, on revenue of $3.32 million.
Jason Nevader submits:
China-Biotics (CHBT) gets it. It is all about becoming the dominant supplier of bulk probiotics to the Chinese functional food industry. After that, it can take on the world.
Over two years ago, the China-Biotics strategy was to increase the number of its retail stores from 60 in April 2008 to 300 stores by April 2009. As of March 31, 2010, the Company had 111 retail stores to sell its Shining branded probiotics supplements, which is an increase of 1 store from its 110 retail stores as of September 30, 2008. Sales from its 111 retail stores only accounted for 14% of last year’s sales. What happened to the additional 189 stores? The Bulk Probiotics Opportunity is Much Bigger.